Immunologic aspects of tropical lung disease

Clinics in Chest Medicine

Volumn 23, Issue 2, 2002, Pages 283-308

  Zumla, Alimuddin I ^a   James, D Geraint ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIGEN; TOXIN;

DUST; GAS EXCHANGE; HOST; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LUNG CIRCULATION; LUNG DISEASE; MICROORGANISM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; TROPICS; ADULT; CHILD; IMMUNOLOGY; LUNG; PHYSIOLOGY; TROPICAL MEDICINE;

ADULT; CHILD; HUMAN; IMMUNE SYSTEM; LUNG; LUNG DISEASES; TROPICAL MEDICINE; HUMANS;

EID: 0036086673     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(01)00005-3     Document Type: Review

References (82)

1. Etiology of childhood community acquired pneumonia and its implications for vaccination
2. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa
3. Defense mechanisms against infections
4. Host defenses and pathogenesis
5. Current concepts on pulmonary host defense mechanisms in children
6. Mucosal immunity in the lung and upper airway
7. Modulating airway defenses against microbes
8. Innate immunity and pulmonary host defense
9. The neutrophil: Function and regulation in innate and humoral immunity
10. Entry and survival of pathogenic mycobacteria in macrophages
11. Eosinophils in asthma and other allergic diseases
12. Pulmonary T cells and eosinophils: Coconspirators or independent triggers of allergic respiratory pathology?
13. Role of the alveolar macrophage in pulmonary bacterial defense
14. Dendritic cells and the control of immunity
15. Dendritic cells as sensors of infection
16. Characterization of dendritic cell populations in the respiratory tract
17. Natural killer cell recognition of HLA class 1 molecules
18. Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis
19. The many faces of host responses to tuberculosis
20. Leishmania, macrophages and complement: A tale of subversion and exploitation
21. The immunology of malarial infection
22. Chemokines and innate immunity
23. Cytokines in innate and adaptive immunity
24. Interferon activation and innate immunity
25. Participation of mammalian defensins and cathlicidins in ant-microbial immunity: Receptors and activities of human defensins and cathelicidin (LL-37)
26. Surfactant regulation of host defense function in the lung: A question of balance
27. Pulmonary collectins and innate host defense of the lung
28. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes
29. The inflammatory response in humans after inhalation of bacterial endotoxin: A review
30. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediateed immune responses in the lung
31. Complement
32. Complement
33. Complement resistance to parasites
34. Th1/Th2 type lymphocyte polarization in asthma
35. B-lymphocytes in the lung: A topic to be revisited
36. Granulomatous infections: An overview
37. Immunological mechanisms in granulomatous lung disease
38. Zur differential diagnose der lungennin-filtrierungen: II. Ueber fluchtige succendan-infiltrate (mit eosinophile)
39. Tropical eosinophilia
40. The syndrome tropical eosinophillia and microfilaria
41. Parasite immune evasion and exploitation: Reflections and projections
42. Molecular basis for evasion of host immunity and pathogenesis in malaria
43. Defense against the immune barrage: Helminth survival strategies
44. Multiple mechanisms of immune evasion by African trypanosomes
45. The immune response to Leishmania: Mechanisms of parasite control and evasion
46. Concomittant infections, parasites and immune responses
47. T cells, superantigens and microbes
48. Microbes and microbial toxins: Paradigms for microbial-mucosal interactions
49. Review of nutrition and immunity in man
50. Nutritional factors and cellular immune responses
51. Nutrition and development of pulmonary defense mechanisms
52. HIV pulmonary immune responses
53. Humoral immune response within the lung in HIV-I infection
54. Approach to the diagnosis of pulmonary disease in patients infected with the human immunodeficiency virus
55. Pneumocystis carinii pneumonia in Malawian children
56. Disease in children infected with HIV in Abidjan. Cote-d'Ivoire
57. Mechanisms of defense in the lung: Lessons from Pneumocystis carinii pneumonia
58. Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology
59. Elevated IL-5 levels in pleural fluid of patients with paragonimiasis westermani
60. Pulmonary manifestations of strongyloidiasis
61. Infection due to strongyloides stercoralis in patients with pulmonary disease
62. Disseminated Strongyloids stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature
63. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis
64. Quoted in: Medicine and the tropics (1984)
65. Human toxocariasis and the visceral larva migrans syndrome: Correlative immunopathology
66. Pulmonary disease in selected protozoal infections
67. Disseminated toxoplasmosis. Unusual presentations in the immunocompromised host
68. Case report: Fulminant Toxoplasma gondii pneumonia in a patient with AIDS
69. Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: A French National Survey
70. Autopsy findings in the acquired immuno-deficiency syndrome (AIDS). A report of 395 cases from the south of France
71. Visceral leishmaniasis in HIV infection and AIDS: Clinical features and response to therapy
72. Pulmonary malignancies in the immunocompromised patient
73. Family size, infection and atopy: The first decade of the "hygiene hypothesis"
74. Atopy in children of families with an anthroposophic lifestyle
75. The inverse association between tuberculin responses and atopic disorder
76. Decreased atopy in children infected with Schistosoma haematobium: A role for parasite-induced interleukin-10
77. Vaccines for the developing world: Current status and furture directions
78. Vaccines out of Africa
79. Vaccine adverse events in the new millenium: Is there reason for concern?
80. Progress towards a malaria vaccine: Efficient induction of protective anti-malaria immunity
81. Genetic subtypes, humoral immunity and Human immunodeficiency virus type I vaccine development
82. Novel nonantibiotic therapies for pneumonia